Healthtech firm launches world’s first consumer epigenetic testing kit with £1.12m investment

Jan 10, 2019 · bdaily.co.uk

Fy38mvej06qkq0hcuv3qjjszmcp5tentqhuzlfaj

Healthtech company Chronomics has raised seven-figure seed funding and launched the world’s first consumer epigenetic testing kit.

The company has secured over £1.12m funding to date, including significant investment from venture capital firm Anthemis and follow-on backing from SOSV.

Other investors in Chronomics include angel Laurence Garrett, senior partner at Highland Europe.

Chronomics is seeking to revolutionise attitudes towards health management. It offers an epigenetic saliva test that profiles specific lifestyle and environmental indicators and provides accurate insights into an individual’s health, including their biological age and metabolic status.

Read Complete Article

RT @HelloUpstream: We're organising our #events for 2019 and would love to hear from you on what topics you'd like us to cover? #startups…

One of my priorities is to tackle violence against women and girls in the capital. I’ve repeatedly called for legis… https://t.co/EvFUbglIx0

#TechX365: Investment is a big deal in the tech startup world, with billions getting invested into thousands of sta… https://t.co/QM4gKXw7wu

Game of Clouds: Lock-In is Coming https://t.co/Cen6T2y4YE via @jperlow

The US Treasury's plan to lift sanctions on companies controlled by Russian billionaire Oleg Deripaska has run into… https://t.co/hQ32TiMOc5